Summary
Clinical trials are the backbone for advancing therapeutic options for patients diagnosed with cancer. Yet only 7.1% of patients with cancer participate in clinical trials in the United States. In this article, we review some of the reasons for poor accrual and discuss potential solutions.
©2024 American Association for Cancer Research
2024
American Association for Cancer Research
You do not currently have access to this content.
RSS Feeds